The Grand Challenges in Global Health program in 2011 awarded more than $31 million in new grants to fund innovative ideas for point-of-care diagnostics in the developing world. Learn more about some of the projects.
To open the 2012 Grand Challenges meeting, Peter Singer, CEO of Grand Challenges Canada, emphasized the importance of "integrated innovation," the combination of science, technology, social and business innovation.
At the 2012 Grand Challenges meeting Welcome Session, Joseph Rotman, Chairman of the Board of Grand Challenges Canada, highlighted Grand Challenges Canada's work to improve the lives of people in low- and middle- income countries around the world by stimulating innovation.
The 2012 Grand Challenges meeting Opening Plenary Session featured Peter Singer, Mario Merialdi, Renuka Gadde, Wendy Taylor, Carol Dahl, Phil Weilerstein, Omer Imtiazuddin, and Rebekah Young discussing how to move from a pipeline of innovation to impact at scale.
This 2012 Grand Challenges meeting Scientific Keynote Session featured three of the most persistent global health challenges–HIV, malaria, and TB. Learn more about Dr. Wendy Stevens' work in HIV/TB point-of-care technologies, Dr. Clifton Barry’s investigation into fixing the TB drug pipeline, and Dr. Sangeeta Bhatia's research on manipulating liver cells for malaria drug discovery.
This 2012 Grand Challenges meeting Scientific Keynote Session featured David Kaslow of the PATH Malaria Vaccine Initiative (MVI) discussing work on malaria vaccines and Tom Evans of Aeras discussing work on TB vaccines.
This 2012 Grand Challenges meeting Plenary Session featured representatives from key partners, including Brazil, India, Israel, South Africa, Thailand and the United States. Learn more about how they're applying the Grand Challenges model to key domestic and international priorities.
The 2012 Grand Challenges meeting Closing Plenary Session featured Abdallah Daar, Gus Nossal, Mwele Malecela and Christine Debouck discussing the Grand Challenges movement – how it has evolved, how it can be more effective, and where it is going in the future.